ストックスクリーナーアプリを入手
131.93
0.69%
0.90
アフターアワーズ：
132.00
0.07
+0.05%
前日終値:
$131.03
開ける：
$132.06
24時間の取引高:
850.44K
Relative Volume:
1.02
時価総額：
$7.44B
収益：
$738.26M
当期純損益:
$48.89M
株価収益率:
152.61
EPS:
0.8645
ネットキャッシュフロー:
$91.69M
1週間 パフォーマンス:
+10.15%
1か月 パフォーマンス:
+15.53%
6か月 パフォーマンス:
-11.76%
1年 パフォーマンス:
+4.19%
1日の値動き範囲:
$131.30
$133.55
1週間の範囲:
$115.45
$133.55
52週間の値動き範囲:
$109.66
$175.77
Repligen Corp Stock (RGEN) Company Profile
Compare RGEN vs ISRG, BDX, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
131.93 | 7.39B | 738.26M | 48.89M | 91.69M | 0.8645 |
ISRG
Intuitive Surgical Inc
|
468.36 | 165.94B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
155.52 | 44.30B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
80.73 | 38.96B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
47.93 | 38.69B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
228.80 | 33.61B | 5.40B | 1.49B | 1.78B | 10.12 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-01 | 開始されました | HSBC Securities | Buy |
| 2025-09-22 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-07-22 | 再開されました | Stephens | Overweight |
| 2025-06-24 | 開始されました | Barclays | Overweight |
| 2025-04-29 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | 開始されました | Evercore ISI | In-line |
| 2025-02-10 | 開始されました | TD Cowen | Buy |
| 2024-12-17 | 開始されました | Canaccord Genuity | Hold |
| 2024-11-14 | 開始されました | Wolfe Research | Peer Perform |
| 2024-08-28 | 開始されました | Wells Fargo | Overweight |
| 2024-06-26 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-06-18 | 開始されました | Guggenheim | Neutral |
| 2023-12-04 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2023-07-20 | 開始されました | Wells Fargo | Overweight |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-03-28 | 開始されました | The Benchmark Company | Buy |
| 2022-12-14 | 開始されました | Deutsche Bank | Hold |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | 開始されました | UBS | Buy |
| 2021-10-14 | 開始されました | Exane BNP Paribas | Outperform |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-05-07 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-23 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-11-15 | 開始されました | Stifel | Buy |
| 2019-11-01 | アップグレード | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | 開始されました | SVB Leerink | Outperform |
| 2019-08-28 | 繰り返されました | First Analysis Sec | Outperform |
| 2019-08-23 | 再開されました | Stephens | Overweight |
| 2019-07-22 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | アップグレード | CL King | Neutral → Buy |
| 2018-11-12 | ダウングレード | CL King | Buy → Neutral |
| 2018-09-26 | 開始されました | H.C. Wainwright | Neutral |
| 2017-12-08 | 開始されました | Citigroup | Buy |
| 2017-12-05 | 開始されました | JP Morgan | Overweight |
| 2017-11-13 | 開始されました | CL King | Buy |
| 2017-10-02 | アップグレード | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | 開始されました | William Blair | Outperform |
| 2017-02-13 | アップグレード | Piper Jaffray | Neutral → Overweight |
すべてを表示
Repligen Corp (RGEN) 最新ニュース
Repligen Corp (RGEN) Stock Up 6.9% and Still Undervalued -- GF S - GuruFocus
Repligen Corp stock (US7607591002): Is bioprocessing demand strong enough to unlock new upside? - AD HOC NEWS
Repligen Corporation (RGEN) Stock Forecasts - Yahoo Finance
RGEN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Analyst Lowers Price Target for RGEN Amid Continued Outperform R - GuruFocus
Repligen Corporation (RGEN) stock price, news, quote and history - Yahoo Finance Australia
Repligen (RGEN) Valuation Check After Mixed Share Price Returns And High P/E Multiple - Yahoo Finance
Repligen Corp (RGN.MU) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore
Repligen Corp at Leerink Global Healthcare Conference Transcript - GuruFocus
Repligen (NASDAQ: RGEN) details 2025 growth, CEO pay and governance in 2026 proxy - stocktitan.net
Repligen Corporation (RGEN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Are Options Investors Anticipating Significant Movement in Repligen Shares? - Bitget
Are Options Traders Betting on a Big Move in Repligen Stock? - Zacks Investment Research
Will Repligen Corporation face regulatory challenges2026 Intraday Action & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Repligen Corp (RGEN) Stock Price Quote Today & Current Price Chart - capital.com
Repligen Corp (RGEN) Stock Price Quote Today & Current Price Chart | Capital.com Australia - Capital.com
Repligen Corp Stock: Bioprocessing Leader with Strong Growth in Biopharma Supply Chain - AD HOC NEWS
RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know - Yahoo Finance
Repligen Corp (RGEN) Trading Down 3.38% on Mar 27 - GuruFocus
Vanguard amends Schedule 13G/A for Repligen (RGEN): reports 0 shares - Stock Titan
Repligen (RGEN) Down 13.5% Since Last Earnings Report: Can It Rebound? - finance.yahoo.com
RGEN PE Ratio & Valuation, Is RGEN Overvalued - Intellectia AI
E. Ohman J or Asset Management AB Takes Position in Repligen Corporation $RGEN - MarketBeat
Repligen (RGEN) SVP R&D Ralf Kuriyel receives new stock options and RSUs - Stock Titan
Repligen (RGEN) CEO receives 25,890 options and 24,134 RSUs - Stock Titan
Repligen (NASDAQ: RGEN) COO granted options and 7,751 RSUs - Stock Titan
Repligen (RGEN) CFO awarded stock options and 7,751 restricted stock units - Stock Titan
RGEN: HC Wainwright & Co. Raises Price Target for Repligen | RGE - GuruFocus
H.C. Wainwright raises Repligen stock price target on strong growth By Investing.com - Investing.com Canada
H.C. Wainwright raises Repligen stock price target on strong growth - Investing.com
Repligen (NASDAQ:RGEN) Price Target Raised to $208.00 - MarketBeat
Hudson Bay Capital Management LP Invests $2.81 Million in Repligen Corporation $RGEN - MarketBeat
Repligen Conference: CEO touts differentiated bioprocessing portfolio; CFO targets 30% EBITDA margin - Yahoo Finance
Republic Services Inc stock shines with eighth World's Most Ethical Companies honor and analyst upgr - AD HOC NEWS
Repligen Corp stock drops 3.17% on NASDAQ amid biotech sector pressures and upcoming earnings - AD HOC NEWS
Repligen Earnings Beat Puts Focus On Analytics Growth And Rich Valuation - Yahoo Finance
Alliancebernstein L.P. Buys 197,778 Shares of Repligen Corporation $RGEN - MarketBeat
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack - Yahoo Finance
270,000 Shares in Repligen Corporation $RGEN Acquired by Iron Triangle Partners LP - MarketBeat
Fred Alger Management LLC Boosts Position in Repligen Corporation $RGEN - MarketBeat
Repligen Corporation $RGEN Shares Acquired by Bamco Inc. NY - MarketBeat
Schroder Investment Management Group Purchases 254,212 Shares of Repligen Corporation $RGEN - MarketBeat
Repligen Corporation $RGEN Shares Sold by Blue Whale Capital LLP - MarketBeat
Repligen at Leerink Conference: Strategic Growth and Challenges - Investing.com
Reassessing Repligen (RGEN) Valuation After Sector Pullback And Profitability Concerns - Yahoo Finance
Evaluating Repligen (RGEN) After Sharp Share Price Declines and Conflicting Valuation Signals - Yahoo Finance
Reassessing Repligen (RGEN) Valuation After Healthcare Jobs Shock And Margin Concerns - simplywall.st
Market Moves: Whats the analyst consensus on Repligen Corporation2026 Sentiment & Expert Approved Trade Ideas - baoquankhu1.vn
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know - Yahoo Finance
Repligen Corporation to Present at Upcoming March Conferences - ChartMill
RGEN SEC FilingsRepligen 10-K, 10-Q, 8-K Forms - Stock Titan
Repligen Corp (RGEN) 財務データ
収益
当期純利益
現金流量
EPS
0.06%
1.84%
大文字化:
|
ボリューム (24 時間):